alexa Zhabiz Golkar | Voorhees College

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Zhabiz Golkar

Zhabiz Golkar Zhabiz Golkar
Assistant Professor
Department of Biology Division of Health and Natural Science Voorhees College>

Dr. Golkar research efforts focus on the emergence of pathogenic multiple drug resistant (MDRs) microorganisms which have become a critical problem in modern medicine, particularly because of the concomitant increase in immunocompromised patients due to transplantation, autoimmune disorders and various viral infections, particularly HIV-1.  Involve building strength in each of the focal areas of my research program, as outlined above in more emphasis on CRISPR/Cas9. CRISPR/Cas9 is simpler, quicker, more precise and versatile than current genomic engineering techniques - a kind of one-stop genomic editing shop.
Dr. Golkar believes CRISPR/Cas9 can be used with great precision to selectively disable or add several genes at once in human cells, offering a potent new tool to understand and treat complex genetic diseases. The technology combines RNA molecules with an enzyme known as Cas9 to target specific DNA sequences. The enzyme cuts the DNA in a precise location, so that researchers can either knock out the gene’s activity or patch in a healthy gene. Since every gene’s DNA has an RNA counterpart, virtually any gene can be targeted by using a specific RNA sequence. And since only one type of enzyme is needed, many genes can be edited at the same time.


Research Interest

Cancer Biology; Molecular and Cell Biology; Clinical Microbiology; Infectious disease


Crisprs/Cas9 May Provide New Method for Drug Discovery and Development
Zhabiz Golkar, Lugenia Rochelle, Omar Bagasra
Research Article: J Mol Biomark Diagn 2016, 7: 280
DOI: 10.4172/2155-9929.1000280
Experimental Phage Therapy on Multiple Drug Resistant Pseudomonas aeruginosa Infection in Mice
Zhabiz Golkar, Omar Bagasra and Nusrat Jamil
Research Article: J Antivir Antiretrovir 2013, S10: 005
DOI: 10.4172/jaa.S10-005
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version